Minova: rosuvastatin calcium tablets and atorvastatin calcium tablets of the joint venture have obtained the drug registration approval
According to the announcement on the website of the State Drug Administration of the people's Republic of China on the release of information on drug approval documents to be collected on July 30, 2021, the application for approval of the production of rosuvastatin calcium tablets (5mg, 10mg, 20mg) and atorvastatin calcium tablets (10mg, 20mg, 40mg) submitted by the company's joint venture Ningbo kelkang meinovartis Pharmaceutical Co., Ltd. ("kelkang meinovartis") has been completed, The drug approval certificate was issued on July 28, 2021.
This text is a result of machine translation.
Related companies：
In-depth
Briefing Jun 08, 2022 11:13 PM
· Automotive
Henan and Geely signed a strategic cooperation agreement to strengthen cooperation in new energy vehicle manufacturing and other fields
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jun 06, 2022 10:00 PM
Starting from RMB 181600, smart genie 1 will be delivered in the fourth quarter
Briefing Mar 15, 2022 10:49 AM
SASAC: from January to February, central enterprises realized a net profit of 282.17 billion yuan, a year-on-year increase of 20.4%
Automotive
Geely’s Radar Auto Launches RD6 Electric Pickup in China
The top-tier, long-range version is priced at CNY 268,800 (USD 37,390) which is still ridiculously affordable by US standards. Other RD6 features include 6 kW vehicle-to-load (V2L) capabilities, plus 220V and 12V interfaces.
Nov 11, 2022 03:42 PM
Briefing Feb 17, 2022 06:09 PM
· Technology
Guangdong hydropower: won the bid for the second batch of photovoltaic power generation projects in Aksu, Xinjiang in 2021
Briefing Feb 11, 2022 03:19 PM
· Technology
Last period: Copper inventory increased by 66213 tons this week, and aluminum inventory increased by 29888 tons
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth